Technical Analysis for BTI - biOasis Technologies Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.85% | |
| Wide Bands | Range Expansion | 0.85% | |
| Overbought Stochastic | Strength | 0.85% | |
| Down 3 Days in a Row | Weakness | 0.85% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 0.43% |
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Get a Trading Sidekick!
- Earnings date: 2024-01-17
biOasis Technologies Inc. Description
biOasis Technologies Inc. is a development-stage biopharmaceutical company, which is focused on research, development and commercialization of technologies and products that are intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. The Company researches and develops products for diagnosis and treatment of neurological diseases and disorders. It is engaged in the development of its vectors Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin (MTf or p97) and portions thereof. Transcend delivery molecules have the ability to transport a range of molecules across the BBB. The Company owns approximately 30 the United States and foreign patents/applications related to p97 as a BBB delivery vector and as a biomarker for Alzheimer's disease.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Transport Medicine Pharma Pharmaceutical Delivery Disease Biology Diseases Biopharmaceutical Disorders Alzheimer's Disease Neurological Diseases Neurology Biomarker Brain Central Nervous System Nervous System
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.2 |
| 52 Week Low | 0.005 |
| Average Volume | 72,364 |
| 200-Day Moving Average | 0.082 |
| 50-Day Moving Average | 0.242 |
| 20-Day Moving Average | 0.596 |
| 10-Day Moving Average | 1.186 |
| Average True Range | 0.050 |
| RSI (14) | 94.40 |
| ADX | 73.76 |
| +DI | 88.663 |
| -DI | 2.478 |
| Chandelier Exit (Long, 3 ATRs) | 1.049 |
| Chandelier Exit (Short, 3 ATRs) | 0.156 |
| Upper Bollinger Bands | 1.777 |
| Lower Bollinger Band | -0.586 |
| Percent B (%b) | 0.75 |
| BandWidth | 396.675 |
| MACD Line | 0.323 |
| MACD Signal Line | 0.268 |
| MACD Histogram | 0.0549 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.203 | ||||
| Resistance 3 (R3) | 1.202 | 1.193 | 1.199 | ||
| Resistance 2 (R2) | 1.193 | 1.188 | 1.194 | 1.197 | |
| Resistance 1 (R1) | 1.187 | 1.184 | 1.183 | 1.188 | 1.196 |
| Pivot Point | 1.178 | 1.178 | 1.176 | 1.179 | 1.178 |
| Support 1 (S1) | 1.172 | 1.173 | 1.168 | 1.173 | 1.164 |
| Support 2 (S2) | 1.163 | 1.169 | 1.164 | 1.163 | |
| Support 3 (S3) | 1.157 | 1.163 | 1.161 | ||
| Support 4 (S4) | 1.158 |
